Elena Ridloff is Director of Kronos Bio, Inc.. Currently has a direct ownership of 13,963 shares of KRON, which is worth approximately $14,242. The most recent transaction as insider was on Jun 22, 2023, when has been sold 11,333 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 14K
0% 3M change
430.91% 12M change
Total Value Held $14,242

Elena Ridloff Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jun 22 2023
BUY
Grant, award, or other acquisition
-
11,333 Added 44.8%
13,963 Common Stock
Oct 14 2020
BUY
Open market or private purchase
$49,970 $19.0 p/Share
2,630 Added 50.0%
2,630 Common Stock

Also insider at

ACAD
ACADIA PHARMACEUTICALS INC Healthcare
KYMR
Kymera Therapeutics, Inc. Healthcare
ER

Elena Ridloff

Director
San Diego, CA

Track Institutional and Insider Activities on KRON

Follow Kronos Bio, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KRON shares.

Notify only if

Insider Trading

Get notified when an Kronos Bio, Inc. insider buys or sells KRON shares.

Notify only if

News

Receive news related to Kronos Bio, Inc.

Track Activities on KRON